Ana Sayfa | Dergi Hakkında | Yayın Kurulu | Danışman Kurulu | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | İletişim  
2003, Cilt 17, Sayı 4, Sayfa(lar) 395-397
[ Türkçe Özet ] [ PDF ] [ Benzer Makaleler ]
PREVALENCE OF ANTI-HEPATITIS DELTA VIRUS (ANTI-HDV) AND ANTI-HEPATITIS C VIRUS (ANTI-HCV) ANTIBODIES IN CHRONIC HEPATITIS B PATIENTS
Salih CESUR1, Samet Vasfi KUVAT2, Aydın ÇİFTÇİ3, İsmail BALIK2
1Refik Saydam Hıfzıssıhha Merkezi, Tüberküloz Referans ve Araştırma Laboratuvarı, Ankara
2Ankara Üniversitesi Tıp Fakültesi, Klinik Bakteriyoloji ve İnfeksiyon Hastalıkları Anabilim Dalı, Ankara
3Ankara Numune Eğitim ve Araştırma Hastanesi, Dahiliye Kliniği, Ankara
Keywords: Chronic hepatitis B, anti-Hepatitis D Virus (anti-HDV), anti-Hepatitis C Virus (anti-HCV), seroprevalence

The aim of this study was to determine the prevalence of Hepatitis Delta Virus (HDV) and Hepatitis C Virus (HCV) in patients chronically infected with Hepatitis B Virus (HBV). The prevalence of anti-HDV (total) and anti-HCV antibodies was investigated in totally 275 patients with chronic hepatitis B or asymptomatic HBV carriers. Of total 275 patients positive for HBsAg, 15 (%5.45) were found to be seropositive for HDV and two (%0.72) seropositive for HCV. Anti-HDV seropositivity was found to be %4.78 (11/230) and %8.8 (4/45) in HBV carriers and chronic hepatitis B, respectively. Two of asymtomatic carriers (%0.86) were seropositive for anti-HCV, but none of chronic hepatitis B patients was seropositive for anti- HCV. It is concluded that HDV and HCV infections should be investigated in patients with chronic hepatitis B.

[ Türkçe Özet ] [ PDF ] [ Benzer Makaleler ]
Ana Sayfa | Dergi Hakkında | Yayın Kurulu | Danışman Kurulu | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | İletişim